MS patients in rural areas are 17% less likely to receive DMTs than those in urban areas, a study of Alberta, Canada, ...

Rituximab, a lower-cost treatment, may be as effective at managing RRMS as the approved therapy Ocrevus, a new study from ...

This week's Guest Voice features Aranzazu Calzado, who says she was terrified to learn she had MS. Today, she's proud of her ...

Aranzazu Calzado, known to friends as Zazu, has lived in Houston since 1996 after moving from Spain. Diagnosed with primary ...

MS patients in the U.S. with Medicaid coverage have worse disease outcomes compared with those who have private insurance, a ...